Pharma major GlaxoSmithKline and software giant Tata Consultancy Services on Tuesday signed a 'multi-year, multi-million dollar' contract to set up a global drug development support centre in Mumbai.
Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.
Wockhardt's US subsidiary, Wockhardt USA, has launched Ondansetron injection in the United States on December 26.
Big Pharma execs may not know more about the disease than the rest of us, but a group of them are using their power to fight it.
In the international market, Pfizer completed its acquisition of Wyeth in 2009.
FMCG moves fast, while real estate yields ground and metals lose their lustre. The star of 2008 so far has been Hindustan Unilever; the multinational FMCG player has actually gained 20.45 per cent between January 1, 2008 and December 24, 2008.
Take the Rediff Business Quiz and see if you know which are the world's top steel, pharma, wine comapnies.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Govt bans brands with annual sales worth Rs 3,728 crore.
FIPB had taken up these three proposals in its meeting in August, but the decision on them was kept in abeyance.
Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.
The NPPA letter was issued to GSK on Wednesday.
GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
NPPA suggests expanding the list of essential medicines whose prices are controlled
Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
DRL launched four new products in North America during the previous quarter.
The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.
In separate statements, the two companies said they will combine Novartis' over-the-counter division with GSK's consumer business, creating a new world-leading consumer healthcare business with $10 billion in annual sales.
'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Markets end in red; bluechips struggle to keep pace.
Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.
Sensex rises, Nifty ends at record high; RIL shares rally.
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
The benchmark BSE Sensex reclaimed the 28,000 mark, spurting by 409 points or 1.4% at 28,114 and Nifty settled above the 8,500 mark at 8,532, gains of 111 points.
The Sensex ended above 27,000 for the first time while the Nifty topped 8,100.
Some big ones hoard cash unduly and others borrow to keep up payments to shareholders
Markets rebound with financials leading the gains on hopes of a peaceful solution to the turmoil in Ukraine
Move could be aimed at integrating operations with Indian subsidiary.
Tendering the shares in an open offer will lead to higher taxation.
A glance back at some of the important ups and down Indian Inc faced in 2018.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The biotech company's revenues had fallen to as low as Rs 50 cr.
